0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
United States DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States DSUVIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
EUR$2,750USDGBP
United States MAXIGESIC IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
EUR$2,750USDGBP
From
EUR$2,750USDGBP
Migraine - Epidemiology Forecast - 2032 - Product Thumbnail Image

Migraine - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 98 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$7,500USDGBP
Neuropathic Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Neuropathic Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$7,500USDGBP
Opioid-Induced Constipation - Epidemiology Forecast to 2032 - Product Thumbnail Image

Opioid-Induced Constipation - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Chronic and Acute pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic and Acute pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Peripheral Neuropathic Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Peripheral Neuropathic Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Chronic Neuropathic Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Neuropathic Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Ocular pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Ocular pain - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Bladder pain syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bladder pain syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Chronic Ocular Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Ocular Pain - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Opioid Dependence - Epidemiology Forecast to 2032 - Product Thumbnail Image

Opioid Dependence - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Opioid Overdose - Epidemiology Forecast to 2032 - Product Thumbnail Image

Opioid Overdose - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Myofascial Pain Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Myofascial Pain Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Loading Indicator

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen. Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription. The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more